Myungmoon Pharm Co., Ltd. logo

Myungmoon Pharm Co., Ltd. (017180)

Market Closed
15 Jun, 06:30
KRX SM KRX SM
1,307. 00
+17
+1.3178%
56.33B Market Cap
- P/E Ratio
381.7% Div Yield
265,217 Volume
- Eps
1,290
Previous Close
Add Transaction
Day Range
1,296 1,400
Year Range
1,250 2,055
Want to track 017180 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

017180 closed today higher at ₩1,307, an increase of 1.3178% from yesterday's close, completing a monthly decrease of -8.5374% or -₩122. Over the past 12 months, 017180 stock lost -29.3514%.
017180 is not paying dividends to its shareholders.
The last earnings report, released on Mar 20, 2024, missed the consensus estimates by -120.251%. On average, the company has fell short of earnings expectations by -37.7161%, based on the last three reports.
Myungmoon Pharm Co., Ltd. has completed 13 stock splits, with the recent split occurring on May 14, 2020.
The company's stock is traded on one exchange.

017180 Chart

People also search for

Tk Chemical Corp.
1,792
+1.4723%
H.S. Industries Co. Ltd.
2,780
+1.0909%
Motrex Co. Ltd.
7,020
+1.1527%
BYC Co Limited Preferred Stock
25,550
+0.9881%
Digital Daesung Co., Ltd.
7,860
-0.3802%

Myungmoon Pharm Co., Ltd. (017180) FAQ

What is the stock price today?

The current price is ₩1,307.00.

On which exchange is it traded?

Myungmoon Pharm Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 017180.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 381.7%.

What is its market cap?

As of today, the market cap is 56.33B.

Has Myungmoon Pharm Co., Ltd. ever had a stock split?

Myungmoon Pharm Co., Ltd. had 13 splits and the recent split was on May 14, 2020.

Myungmoon Pharm Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Kyu-Huok Lee CEO
KRX SM Exchange
KR7017180001 ISIN
KR Country
291 Employees
27 Dec 2017 Last Dividend
14 May 2020 Last Split
- IPO Date

Overview

MYUNGMOON Pharm Co., Ltd is a distinguished pharmaceutical company that has carved a niche for itself both within South Korea and on the international stage since its inception in 1983. Headquartered in Seoul, South Korea, the company is actively involved in a wide range of pharmaceutical activities that encompass the research, development, production, and distribution of a vast array of pharmaceutical products. The company's dedication to advancing healthcare through innovation is evident in its comprehensive product portfolio, which caters to a variety of therapeutic areas. MYUNGMOON Pharm is dedicated to improving patient care and outcomes, positioning itself as a key player in the pharmaceutical industry.

Products and Services

MYUNGMOON Pharm Co., Ltd offers an extensive range of pharmaceutical products and services catering to various healthcare needs. These include:

  • Prescription Drugs: The company produces a broad spectrum of prescription medications that address a variety of conditions. This includes anti-osteoporosis treatments, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxants, anti-rheumatoid arthritis medications, antibiotics, antifungal agents, respiratory treatments, GI (Gastrointestinal) therapeutics, circulation agents, anti-hypertension drugs, antidiabetic medications, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogenital agents, adrenocortical hormone products, oncology agents, among others, catering to different areas of pharmacotherapy.
  • OTC (Over-the-Counter) Products: In addition to prescription medications, MYUNGMOON Pharm offers a variety of OTC products. This includes treatments for nausea, genitourinary system conditions, gum diseases, liver health supplements, parasiticides, cathartics, antidiarrheal agents, products aiding digestive health, multivitamins, eye nutrition products, eye drops, blood circulation enhancers, circulatory solvents, skin external preparations, and topical analgesic products, providing accessible healthcare solutions to consumers.
  • Health Supplements: The company also markets a range of health supplements intended to support overall health and well-being, offering nutritional support across different health needs and lifestyle requirements.
  • Quasi Drugs: MYUNGMOON Pharm produces quasi drugs, which include products that have medicinal properties and are used for non-disease purposes but can influence health, such as preventing sickness or maintaining and improving health.
  • Blended Juices: Apart from pharmaceuticals and health supplements, the company also offers blended juices, providing a natural and healthy beverage option to consumers looking for dietary supplements and health-centric products.

Contact Information

Address: 7, Gangnam-daero, Seoul, South Korea, 06258
Phone: 82 2 6711 2000